Have a symptom?
See what questions
a doctor would ask.
News » Pregnancy syndrome risks maternal and fetal death

Pregnancy syndrome risks maternal and fetal death

A first-time pregnant woman began to experience right sided abdominal pain and fatigue towards her final trimester, which was diagnosed as HELLP syndrome, a potentially fatal pregnancy related triad of symptoms. HELLP stands for hemolysis, elevated liver enzymes and low platelet count, which is related to pre-eclampsia. Both are caused by unknown factors and can be reversed with delivery of the baby. HELLP is diagnosed by its symptoms and clinical examination, blood tests further support the diagnosis, but it cannot be predicted. It results in death in 1-3% of mothers who are diagnosed with the condition, but it can have lasting effects with end organ failure, including lung, kidney and liver disease. Babies also suffer fatalities directly due to the syndrome and as a result of being born premature, with a 7-20% death rate. They are also at risk of cerebral palsy, blood clots, gastrointestinal problems and premature lung diseases. Symptoms to look out for in pregnant mothers include headaches, extreme fatigue, swelling of body parts, and upper abdomen pain, which can rapidly lead to irreversible organ damage and death.

Source: summary of medical news story as reported by

Related Disease Topics:

Related Symptom Topics:

Article Source Details

About: Pregnancy syndrome risks maternal and fetal death

Date: 29 November 2005


Author: Ellen Crowley Fullerton


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Fatigue associated with MS alleviated by yoga
  • Fatty acids benefit mother and child
  • Fatty liver disease becoming popular
  • Fatty liver disease not linked to cancer development
  • FDA approval of weight loss pill is not necessarily good news
  • FDA approved drug being studied for use in prevention of brain injury and seizures in infants.
  • FDA approves new osteoporosis drug
  • FDA approves new pulmonary arterial hypertension drug
  • FDA approves Prozac use by children
  • FDA bans sexual stimulant diet supplement
  • FDA chastises Pfizer over false advertising of Viagra
  • FDA fails to approve testosterone patch for women
  • FDA finally acknowledges suicide risk associated with antidepressant use in children
  • FDA warns consumers about dietary supplements that treat erectile dysfunction
  • Fears of legal action result in 20 percent increase in breast clinic referrals

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise